O'Shaughnessy Asset Management, LLC Tg Therapeutics, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

  • $10.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$15.2 - $35.51 $53,048 - $123,929
-3,490 Closed
0 $0
Q3 2021

Nov 10, 2021
SELL
$21.78 - $40.45 $59,633 - $110,752
-2,738 Reduced 43.96%
3,490 $116,000
Q2 2021

Aug 09, 2021
BUY
$32.5 - $48.96 $682 - $1,028
21 Added 0.34%
6,228 $241,000
Q1 2021

May 14, 2021
BUY
$41.61 - $54.3 $258,273 - $337,040
6,207 New
6,207 $299,000

Others Institutions Holding TGTX

# of Institutions
340
Shares Held
88.5M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.3B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email